WILMINGTON, Del. (AP) - Delaware will receive $633,000 as part of a $42 million settlement with 34 states with Pfizer Inc. over the drug company's marketing of Zyvox and Lyrica.
Attorney General Beau Biden said Wednesday that the states had alleged Pfizer used unfair and deceptive practices in promoting Zyvox, an antibacterial agent, and Lyrica, which is used to treat fibromyalgia.
Biden said Delaware's share of the money will be paid to the Attorney General's Consumer Protection Fund.
Pfizer issued a prepared statement saying the company denies any wrongdoing and is pleased to resolve the investigation and avoid further expenditures of time and money in litigation.